Vivo Capital, LLC
CIK 1674712
13F filing for Q2 2026・No. 2,437
- Holdings
- US$1.1B
- Quarter change
- −US$107.85M
- Entries
- 47
- Net bought (estimate)
- −US$198.12M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 7
- Sold out 6
- Cut 8
- Added 6
- Corporate actions 0
- Unchanged 26
Largest holdings
47 stocks worth US$1.1B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| Trevi Therapeutics IncCommon | Unchanged | 5,094,668 | US$95.02M | 8.68% |
| Praxis Precision MedicinesCommon | Cut | 271,116 | US$90.77M | 8.29% |
| Erasca IncCommon | Cut | 4,127,412 | US$75.61M | 6.90% |
| AVBPArrivent BioPharma IncCommon | Added | 1,682,097 | US$58.44M | 5.34% |
| Abivax SA - ADRSPONSORED ADS | Added | 414,899 | US$55.29M | 5.05% |
| Tango Therapeutics IncCommon | Cut | 1,379,769 | US$43.13M | 3.94% |
| Corvus Pharmaceuticals IncCommon | Unchanged | 2,805,816 | US$41.92M | 3.83% |
| Bright Minds Biosciences IncCommon | Unchanged | 557,172 | US$39.11M | 3.57% |
| Sinovac Biotech Ltd.SHS | Unchanged | 5,903,000 | US$38.19M | 3.49% |
| Tenax Therapeutics IncCommon | Added | 2,500,000 | US$36.38M | 3.32% |
Sign in (free) to see its 47 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.